ArticleEJIFCC2026
Correlations of Parathormone and Biochemical Parameters in Chronic Kidney Disease.
Article in EJIFCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Biomarkers to Biosensors: Transforming Comorbidity Management in Dialysis Care.Sensors (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hyperparathyroidism due to chronic kidney disease (CKD) is a common complication characterized by elevated parathyroid hormone (PTH) levels secondary to derangements in the homeostasis of calcium and phosphorus. The aim of our study was to figure out PTH, calcium, phosphorus, and magnesium levels in CKD and the possible correlations between them and the stages of CKD. Materials and Methods: We performed a prospective study including 217 outpatients with levels of serum creatinine out of reference range from February 2023 to July 2024. We calculated the glomerular filtration rate (eGFR) with the 2021 CKD-Epi equation using serum creatinine. We used Jamovi Statistical Software version 2.3.28. A "p" value equal to or less than 0.05 was considered statistically significant. Results: We had 105 females (48%) and 112 males (52%), median age 72 years (35-94yrs). We found differences in PTH and phosphorus levels between distinct stages of CKD. For PTH the differences were found between stages IIIa and IV (p<0.001), IIIb and IV (p=0.001), while for phosphorus between stages IIIa and IIIb (p=0.003), IIIa and IV (p<0.001), IIIb and IV (p=0.01). We found correlation between eGFR and PTH (r= -0.360, p=0.001), eGFR and calcium (r=0.169, p=0.015), eGFR and magnesium (r= -0.153, p=0.028), eGFR and phosphorus (r= -0.336, p<0.001). Conclusions: We concluded that there is a statistically significant correlation between PTH and stages of CKD, but the strength of correlation is low, it cannot be generalized, therefore each patient with CKD must be assessed individually.
Indexed as
Identifiers
41659282PMC12882085What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.